Why Is TRULIEVE CANNABIS CO (TRLV) Stock Down Today?

Why TRLV stock is down today

Trulieve Cannabis Co (TRLV) fell 14.39% in the session to $10.62. The decline came after a federal judge paused the cannabis rescheduling case on Tuesday afternoon. The move introduced uncertainty into the sector and weighed on investor sentiment for cannabis stocks.

What Happened

TRLV opened at $11.65, down 6.1% from the previous day's close of $12.41. The stock quickly fell further, hitting a session low of $10.40. The drop followed the announcement that DEA Chief Judge Derek Julius had paused the cannabis rescheduling case. This decision delayed potential regulatory changes that could have benefited the cannabis industry. Cantor Fitzgerald reiterates its rating on Trulieve Cannabis stock, but the broader market reaction was negative. The stock continued to trade lower through the session.

What The Data Shows

TRLV has a market cap of $2.4 billion and is unprofitable, with an earnings per share (TTM) of -2.44. Revenue has declined 3.9% in the trailing twelve months, and the company's net margin is -41.6%. The stock has traded between $7.82 and $12.93 over the past 52 weeks. Volume in the session reached 0.9 million shares, which is 0.6 times the 3-month daily average. The stock has printed two fresh 52-week lows on September 30, 2026. The 30-day average sentiment score is 58 out of 100, while the 7-day average is 53, indicating a recent deterioration in sentiment.

What To Watch

Investors should monitor the ongoing cannabis rescheduling case for any developments. A decision on the case could have a material impact on the sector.